Chimera Investment (NYSE:CIM – Get Free Report) announced its quarterly earnings results on Wednesday. The real estate investment trust reported $0.37 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.10), Zacks reports. Chimera Investment had a net margin of 46.48% and a return on equity of 7.69%.
Chimera Investment Trading Up 1.6 %
Shares of CIM traded up $0.23 during mid-day trading on Thursday, reaching $14.14. 34,169 shares of the company’s stock traded hands, compared to its average volume of 524,304. The company has a debt-to-equity ratio of 3.93, a current ratio of 3.03 and a quick ratio of 3.03. The stock’s 50-day moving average is $14.48 and its two-hundred day moving average is $14.96. Chimera Investment has a 12 month low of $11.28 and a 12 month high of $16.89. The stock has a market cap of $1.14 billion, a P/E ratio of 4.28 and a beta of 1.71.
Chimera Investment Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st were paid a $0.37 dividend. This represents a $1.48 annualized dividend and a yield of 10.47%. The ex-dividend date of this dividend was Tuesday, December 31st. Chimera Investment’s payout ratio is currently 44.85%.
Insider Buying and Selling
Analyst Ratings Changes
Separately, JMP Securities reaffirmed a “market perform” rating on shares of Chimera Investment in a research note on Thursday, January 23rd.
Read Our Latest Research Report on Chimera Investment
About Chimera Investment
Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities.
Further Reading
- Five stocks we like better than Chimera Investment
- Profitably Trade Stocks at 52-Week Highs
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
- Golden Cross Stocks: Pattern, Examples and Charts
- CVS Health: Earnings Beat Ignites Stock Rally
- 3 Warren Buffett Stocks to Buy Now
- Honeywell’s Breakup: Is HON Stock a Sweet Deal for Investors?
Receive News & Ratings for Chimera Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chimera Investment and related companies with MarketBeat.com's FREE daily email newsletter.